Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Low vitamin D level is associated with higher relapse rate in natalizumab treated MS patients.
Management of faecal incontinence and constipation in adults with central neurological diseases.
Update on multiple sclerosis treatments.
c-kit plays a critical role in induction of intravenous tolerance in experimental autoimmune encephalomyelitis.
Anxiety and depressive symptoms in caregivers of multiple sclerosis patients: The role of information processing speed impairment.
Does Disease-Irrelevant Intrathecal Synthesis in Multiple Sclerosis Make Sense in the Light of Tertiary Lymphoid Organs?
Autoimmune disease prevalence in a multiple sclerosis cohort in Argentina.
Supporting work for people with multiple sclerosis.
Neural correlates of alerting and orienting impairment in multiple sclerosis patients.
Long-term benefits of induction therapy in NMO: a case report.
Selective inhibition by riluzole of voltage-dependent sodium channels and catecholamine secretion in adrenal chromaffin cells.
[Rare case of noeffective therapy with natalizumab (tisabri) in a female patient with multiple sclerosis and neutralizing antibodies to the drug.]
Chronic primary central nervous system histoplasmosis in a healthy child with intermittent neurological manifestations.
Human Mesenchymal Stem Cells Upregulate CD1dCD5(+) Regulatory B Cells in Experimental Autoimmune Encephalomyelitis.
Immunomodulatory synergy by combining atorvastatin and rapamycin in the treatment of experimental autoimmune encephalomyelitis (EAE).
Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.
Liver X Receptors differentially modulate central myelin gene mRNA levels in a region-, age- and isoform-specific manner.
Intracellular signaling pathway regulation of myelination and remyelination in the CNS.
MicroRNA regulation of lymphocyte tolerance and autoimmunity.
MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencing.
Sample size estimation for negative binomial regression comparing rates of recurrent events with unequal follow-up time.
Dalfampridine in hereditary spastic paraplegia: a prospective, open study.
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation.
Patient-related factors may affect the outcome of neuropsychological rehabilitation in multiple sclerosis.
From genes to characteristics of multiple sclerosis.
Pages
« first
‹ previous
…
273
274
275
276
277
278
279
280
281
…
next ›
last »